Download Unicorn Signals App

Powered By EquityPandit
Latest News

Ajanta Pharma has launched pain relief tablets in US

On Thursday, Ajanta Pharma has launched eletriptan hydrobromide tablets which is used in treating headaches in the US market.

Ajanta Pharma has said in a BSE filing that “It is a bioequivalent generic version of Relpax tablets. Ajanta Pharma has launched the product in two strengths, 20 mg and 40 mg tablets.”

According to the company Eletriptan hydrobromide tablets is a part of its growing portfolio of products developed for the US market.

Read EquityPandit’s Technical Analysis on Nifty Pharma

Get Daily Prediction & Stocks Tips On Your Mobile